Understanding the genetic make-up of your prostate cancer tumor can open up new paths for treatment. In this recap from our “Ask the Expert” webinar, medical oncologist Dr. Hardeep Phull explores the significance of CDK12 mutations, how they might influence response to therapy, and why PARP inhibitors are becoming a major option in personalized prostate […]

Next steps after an early-stage prostate cancer diagnosis We had the honor of hosting Massachusetts General Hospital’s Dr. Xin Gao during a recent “Ask the Expert” webinar. In this educational session, Dr. Gao provided insights on different treatment paths and exciting advancements in prostate cancer care that patients should know about from last year’s American […]

If you or a loved one has been recently diagnosed with prostate cancer, you may feel overwhelmed with the amount of information available. In our discussion with genitourinary oncologist Dr. Atish Choudhury at Dana-Farber Cancer Institute, we break down the latest advances in prostate cancer care. Watch the full webinar for insights on radiation therapy, […]

We had the opportunity to host Assistant Professor of Urology at UCLA Health Dr. Wayne Brisbane for an illuminating discussion on the power of personalized treatment options in prostate cancer care. Uncover how cutting-edge technology and innovative approaches are revolutionizing treatment in the full webinar, linked below. Watch the full replay here Continue reading for […]

Genetic Markers Every Prostate Cancer Patient Should Know According to the National Cancer Institute, more than half of prostate cancer risk is due to inherited factors. Knowing whether you were born with genetic variants that may contribute to your risk of prostate cancer can guide your treatment options as well as help your family understand […]

Robotic Prostate Surgery for Cancer Explained If you’ve been diagnosed with early-stage prostate cancer, your care team might recommend a surgical procedure called a robotic prostatectomy. For cancer that’s in its earlier stages and hasn’t spread to surrounding tissue, this sophisticated, minimally invasive procedure is often suggested due to the surgeon’s ability to operate on […]

Prostate cancer is classified into standard stages. Staging helps determine the most appropriate treatment approach and prognosis for each individual. Prostate cancer staging involves a combination of screening tests and diagnostic procedures. The prostate-specific antigen (PSA) blood test, digital rectal exams (DREs), imaging studies (such as MRI or ultrasound), and prostate biopsy results may be […]

Prostate cancer is a complex disease that varies in its aggressiveness and potential to spread. To guide treatment decisions, healthcare providers often stratify patients with localized (Stages I to IIIC) prostate cancer into risk groups.  These risk groups are based on clinical characteristics such as tumor stage, Gleason score, prostate-specific antigen (PSA) level, and biopsy […]

Characteristics of prostate tumors play an important role in deriving the stage and risk group of your cancer. By understanding the characteristics, you can better understand the nature and aggressiveness of your prostate cancer. The three clinical characteristics include prostate-specific antigen (PSA), Gleason score, and tumor grade which are determined by blood tests and prostate […]

Facing a prostate cancer diagnosis brings many questions, one of the most pressing being about life expectancy. Thankfully, a range of online tools can help you estimate your prognosis based on various factors. These calculators and nomograms use clinical data to provide insights into survival probabilities and treatment outcomes. In this article, we’ll explore several […]